HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reactions in Nitroimidazole and Methylnitroimidazole Triggered by Low-Energy (0-8 eV) Electrons.

Abstract
Low-energy electrons (0-8 eV) effectively decompose 4-nitroimidazole (4NI) and the two methylated isomers 1-methyl-5-nitroimidazole and 1-methyl-4-nitroimidazole via dissociative electron attachment (DEA). The involved unimolecular decompositions range from simple bond cleavages (loss of H(•), formation of NO2(-)) to complex reactions possibly leading to a complete degradation of the target molecule (formation of CN(-), etc.). At energies below 2 eV, the entire rich chemistry induced by DEA is completely quenched by methylation, as demonstrated in a previous communication (Tanzer, K.; Feketeová, L.; Puschnigg, B.; Scheier, P.; Illenberger. E.; Denifl, S. Angew. Chem., Int. Ed. 2014, 53, 12240). The observation that in 4NI neutral radicals and radical anions are formed via DEA at high efficiency already at threshold (0 eV) may have significant implications for the development of nitroimidazole-based radiosensitizers in tumor radiation therapy.
AuthorsKatrin Tanzer, Linda Feketeová, Benjamin Puschnigg, Paul Scheier, Eugen Illenberger, Stephan Denifl
JournalThe journal of physical chemistry. A (J Phys Chem A) Vol. 119 Issue 25 Pg. 6668-75 (Jun 25 2015) ISSN: 1520-5215 [Electronic] United States
PMID26020684 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anions
  • Nitroimidazoles
  • Radiation-Sensitizing Agents
  • Hydroxyl Radical
  • Hydrogen
  • 4-nitroimidazole
Topics
  • Anions (chemistry)
  • Electrons
  • Hydrogen (chemistry)
  • Hydroxyl Radical (chemistry)
  • Molecular Structure
  • Nitroimidazoles (chemistry)
  • Radiation-Sensitizing Agents (chemistry)
  • Spectrum Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: